Literature DB >> 9624150

Type XIII collagen is identified as a plasma membrane protein.

P Hägg1, M Rehn, P Huhtala, T Väisänen, M Tamminen, T Pihlajaniemi.   

Abstract

The complete primary structure of the mouse type XIII collagen chain was determined by cDNA cloning. Comparison of the mouse amino acid sequences with the previously determined human sequences revealed a high identity of 90%. Surprisingly, the mouse cDNAs extended further in the 5' direction than the previously identified human clones. The 5' sequences contained a new in-frame ATG codon for translation initiation which resulted in elongation of the N-terminal noncollagenous domain by 81 residues. These N-terminal sequences lack a typical signal sequence but include a highly hydrophobic segment that clearly fulfills the criteria for a transmembrane domain. The sequence data thus unexpectedly suggested that type XIII collagen may be located on the plasma membrane, with a short cytosolic N-terminal portion and a long collagenous extracellular portion. These sequence data prompted us to generate antipeptide antibodies against type XIII collagen in order to study the protein and its subcellular location. Western blotting of human tumor HT-1080 cell extract revealed bands of over 180 kDa. These appeared to represent disulfide-bonded multimeric polypeptide forms that resolved upon reduction into 85-95-kDa bands that are likely to represent a mixture of splice forms of monomeric type XIII collagen chains. These chains were shown to contain the predicted N-terminal extension and thus also the putative transmembrane segment. Immunoprecipitation of biotinylated type XIII collagen from surface-labeled HT-1080 cells, subcellular fractionation, and immunofluorescence staining were used to demonstrate that type XIII collagen molecules are indeed located in the plasma membranes of these cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9624150     DOI: 10.1074/jbc.273.25.15590

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  A short sequence in the N-terminal region is required for the trimerization of type XIII collagen and is conserved in other collagenous transmembrane proteins.

Authors:  A Snellman; H Tu; T Väisänen; A P Kvist; P Huhtala; T Pihlajaniemi
Journal:  EMBO J       Date:  2000-10-02       Impact factor: 11.598

2.  The shed ectodomain of type XIII collagen affects cell behaviour in a matrix-dependent manner.

Authors:  Marja-Riitta Väisänen; Timo Väisänen; Taina Pihlajaniemi
Journal:  Biochem J       Date:  2004-06-15       Impact factor: 3.857

3.  Antibodies targeting the calcium binding skeletal muscle protein calsequestrin are specific markers of ophthalmopathy and sensitive indicators of ocular myopathy in patients with Graves' disease.

Authors:  B Gopinath; R Musselman; N Beard; S El-Kaissi; J Tani; C-L Adams; J R Wall
Journal:  Clin Exp Immunol       Date:  2006-07       Impact factor: 4.330

4.  Collagen XIII Is Required for Neuromuscular Synapse Regeneration and Functional Recovery after Peripheral Nerve Injury.

Authors:  Zarin Zainul; Anne Heikkinen; Hennariikka Koivisto; Iina Rautalahti; Mika Kallio; Shuo Lin; Heli Härönen; Oula Norman; Markus A Rüegg; Heikki Tanila; Taina Pihlajaniemi
Journal:  J Neurosci       Date:  2018-04-06       Impact factor: 6.167

5.  Identification and characterization of the integrin alpha2beta1 binding motif in chondroadherin mediating cell attachment.

Authors:  Lisbet Haglund; Viveka Tillgren; Laura Addis; Christina Wenglén; Anneliese Recklies; Dick Heinegård
Journal:  J Biol Chem       Date:  2010-12-02       Impact factor: 5.157

6.  The shed ectodomain of type XIII collagen associates with the fibrillar fibronectin matrix and may interfere with its assembly in vitro.

Authors:  Marja-Riitta Väisänen; Timo Väisänen; Hongmin Tu; Päivi Pirilä; Raija Sormunen; Taina Pihlajaniemi
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

Review 7.  Role of extracellular matrix proteins and their receptors in the development of the vertebrate neuromuscular junction.

Authors:  Neha Singhal; Paul T Martin
Journal:  Dev Neurobiol       Date:  2011-11       Impact factor: 3.964

8.  Abnormal adherence junctions in the heart and reduced angiogenesis in transgenic mice overexpressing mutant type XIII collagen.

Authors:  M Sund; R Ylönen; A Tuomisto; R Sormunen; J Tahkola; A P Kvist; S Kontusaari; H Autio-Harmainen; T Pihlajaniemi
Journal:  EMBO J       Date:  2001-09-17       Impact factor: 11.598

9.  Muscle-derived collagen XIII regulates maturation of the skeletal neuromuscular junction.

Authors:  Anne Latvanlehto; Michael A Fox; Raija Sormunen; Hongmin Tu; Tuomo Oikarainen; Anu Koski; Nikolay Naumenko; Anastasia Shakirzyanova; Mika Kallio; Mika Ilves; Rashid Giniatullin; Joshua R Sanes; Taina Pihlajaniemi
Journal:  J Neurosci       Date:  2010-09-15       Impact factor: 6.167

10.  A mutant collagen XIII alters intestinal expression of immune response genes and predisposes transgenic mice to develop B-cell lymphomas.

Authors:  Anne Tuomisto; Malin Sund; Jenni Tahkola; Anne Latvanlehto; Eeva-Riitta Savolainen; Helena Autio-Harmainen; Annikki Liakka; Raija Sormunen; Jussi Vuoristo; Anne West; Riitta Lahesmaa; Herbert C Morse; Taina Pihlajaniemi
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.